Benefits
FDA-Approved Cholesterol Health Claim
Barley beta-glucan carries FDA-approved health claim for cholesterol management — at 3 g/day intake, may reduce risk of coronary heart disease.
Cholesterol Reduction via Bile Acid Binding
Soluble beta-glucan binds bile acids; liver uses cholesterol to make new bile acids; net cholesterol reduction.
Glycemic Control
Beta-glucan slows carbohydrate digestion and absorption — supports postprandial glucose modulation.
Satiety Support
Viscous soluble fiber promotes satiety — relevant to weight management.
Gut Microbiome Fermentation
Colonic fermentation produces short-chain fatty acids (SCFAs) supporting gut and immune health.
Water-Soluble Form
BarliV's water-soluble beta-glucan enables beverage and food applications without significant texture impact at appropriate doses.
Mechanism of action
Bile Acid Binding (Primary)
Soluble beta-glucan forms viscous gel that binds bile acids in intestine; bile acids excreted instead of recycled; liver synthesizes new bile from cholesterol; net cholesterol reduction.
Slowed Gastric Emptying
Viscous fiber slows gastric emptying — modulates postprandial glucose and supports satiety.
Beta-Glucan Structure
1,3/1,4 beta-glucan from barley distinct from yeast 1,3/1,6 beta-glucan (which has different immune-focused mechanism).
Colonic Fermentation
Soluble fiber fermentation produces SCFAs (butyrate, acetate, propionate) supporting gut and metabolic health.
Clinical trials
Multiple meta-analyses of barley beta-glucan for cholesterol management.
Various populations including hypercholesterolemic.
Consistent LDL cholesterol reductions with 3+ g/day barley beta-glucan; supports FDA health claim.
Multiple beta-glucan trials on postprandial glucose response.
Adults including pre-diabetic and diabetic.
Reduced postprandial glucose response; modest improvements in glycemic markers.